Inventor · disambiguated record
Zelin Sheng
Also filed as: SHENG ZELIN
4 granted patents·5 pending applications·29 citations·filing 2003–2022
72Inventor score
Files withSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD6SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD1THERACOS INC1
Top patents by PatentIndex Score
9 records- 0191US11459327B1Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 4, 2022·6 cites·6 claims
- 0289US7838498B2Benzylic glycoside derivatives and methods of useTHERACOS INC·Filed 2008·Granted Nov 23, 2010·19 cites·37 claims
- 0372US9604935B2Deuterated phenyl amino pyrimidine compound and pharmaceutical composition containing the sameSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2014·Granted Mar 28, 2017·3 cites·11 claims
- 0467US10544185B2Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 28, 2020·1 cites·17 claims
- 0563US2023105745A1Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0661US2025051444A1Multi-specific t cell engagers comprising lrrc15 antigen-binding domainSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0752US2023008368A1Imidazoquinoline substituted phosphoric ester agonist, and preparation therefor and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 0833US2003215787A1Modulators of the CLC-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease statesFiled 2003·Application pending·0 cites
- 0922US2013012548A1Deuterium-substituted omega-diphenylurea and derivatives thereof and pharmaceutical compositions comprising the compoundsSUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →